Clinical Trials in China: Unlocking the Potential of Advanced Therapies Presented by Novotech and Endpoints News BOSTON, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today an expert panel webinar on Clinical Trials in...

Novotech Joins Expert Panel at AACR for eChinaHealth Session on Collaborating with China’s Cancer Research Sector SYDNEY, Australia, April 13, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO joins oncology leaders at the eChinaHealth panelist session and dinner at AACR. The...

Data Shows 50% of New Trials Have Sites in Asia Pacific SINGAPORE, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publication by GlobalData and Novotech found almost 50% of...

Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials SINGAPORE, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Frost & Sullivan Company of the Year Award 2022 for Best Practices in...